For over 10 years now TriLink has offered cutting edge services to researchers in the fields of gene therapy, nucleoside chemotherapy, oligonucleotide therapy and diagnostics. TriLink specializes in the modification of oligonucleotides and nucleoside triphosphates. We provide a wide range of services from radioactive labeling to conjugation to custom research. With a proven track record of manufacturing challenging novel oligonucleotides and nucleotides, high-purity compounds and excellent technical support are the hallmarks of TriLink. TriLink’s founders have been on the forefront of the advancements in oligonucleotide